Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Raskova

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
The American Journal of Medicine|May 1, 1984
Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysisJ Raskova, I Ghobrial, S M Shea, et al.
Transplantation Proceedings|February 1, 1995
Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cellsI Barkis, K Hadjiyannaki-Koniavitou, A Vareltzides, et al.
Virology|December 1, 1989
C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunityD Urbanelli, Y Sawada, J Raskova, et al.
Clinical and Experimental Immunology|July 1, 1989
Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic patternK Raska, H C Kim, K Raska, et al.
Bratislavske Lekarske Listy|August 23, 2002
Immune thrombocytopenic purpura in childrenE Hostynova, J Cap, J Lukac, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Interleukin-1 receptors and receptor antagonist in haemodialysisD Donati, D Degiannis, E Mazzola, et al.
Diagnostic Immunology|January 1, 1986
T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generationJ Raskova, I Ghobrial, S M Shea, et al.
American Journal of Nephrology|January 1, 1990
Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranesD Degiannis, M Czarnecki, D Donati, et al.
Archives of Internal Medicine|January 1, 1987
B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysisJ Raskova, I Ghobrial, D K Czerwinski, et al.
The New England Journal of Medicine|May 17, 1984
Cyclosporine-like substances not detected in patients with AIDSH F Schran, A E Hassell, D L Winter, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
The American Journal of Medicine|May 1, 1984
Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysisJ Raskova, I Ghobrial, S M Shea, et al.
Transplantation Proceedings|February 1, 1995
Effect of rapamycin on the in vitro release of soluble interleukin-2 receptor by phytohemagglutinin, phorbol myristate acetate, and ionomycin-activated peripheral blood mononuclear cellsI Barkis, K Hadjiyannaki-Koniavitou, A Vareltzides, et al.
Virology|December 1, 1989
C-terminal domain of the adenovirus E1A oncogene product is required for induction of cytotoxic T lymphocytes and tumor-specific transplantation immunityD Urbanelli, Y Sawada, J Raskova, et al.
Clinical and Experimental Immunology|July 1, 1989
Human immunodeficiency virus (HIV) infection in haemophiliacs: long-term prognostic significance of the HIV serologic patternK Raska, H C Kim, K Raska, et al.
Bratislavske Lekarske Listy|August 23, 2002
Immune thrombocytopenic purpura in childrenE Hostynova, J Cap, J Lukac, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 1, 1997
Interleukin-1 receptors and receptor antagonist in haemodialysisD Donati, D Degiannis, E Mazzola, et al.
Diagnostic Immunology|January 1, 1986
T cells in patients undergoing chronic hemodialysis: mitogenic response, suppressor activity, and interleukin-2 production and receptor generationJ Raskova, I Ghobrial, S M Shea, et al.
American Journal of Nephrology|January 1, 1990
Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranesD Degiannis, M Czarnecki, D Donati, et al.
Archives of Internal Medicine|January 1, 1987
B-cell activation and immunoregulation in end-stage renal disease patients receiving hemodialysisJ Raskova, I Ghobrial, D K Czerwinski, et al.
The New England Journal of Medicine|May 17, 1984
Cyclosporine-like substances not detected in patients with AIDSH F Schran, A E Hassell, D L Winter, et al.
Pageof 6